ZENTEK LTD. (ZAY0) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ZENTEK LTD. (ZAY0) has a cash flow conversion efficiency ratio of -0.158x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.95 Million ≈ $-2.28 Million USD) by net assets (€12.34 Million ≈ $14.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ZENTEK LTD. - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how ZENTEK LTD.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ZAY0 liabilities breakdown for a breakdown of total debt and financial obligations.
ZENTEK LTD. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ZENTEK LTD. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jia Wei Lifestyle Inc
TW:3557
|
-0.181x |
|
Artifex Mundi SA
WAR:ART
|
-0.016x |
|
MINDs Lab Inc.
KQ:377480
|
-0.082x |
|
Country Group Holdings Public Company Limited
BK:CGH
|
0.024x |
|
Anabatic Technologies Tbk PT
JK:ATIC
|
-0.230x |
|
G.I. Tech Co. Ltd.
KQ:382480
|
0.020x |
|
Cape EMS Berhad
KLSE:5311
|
-0.093x |
|
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
|
0.018x |
Annual Cash Flow Conversion Efficiency for ZENTEK LTD. (2022–2025)
The table below shows the annual cash flow conversion efficiency of ZENTEK LTD. from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see ZAY0 market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | €14.75 Million ≈ $17.24 Million |
€-6.28 Million ≈ $-7.34 Million |
-0.426x | -6.72% |
| 2024-03-31 | €20.17 Million ≈ $23.58 Million |
€-8.05 Million ≈ $-9.41 Million |
-0.399x | +6.40% |
| 2023-03-31 | €30.38 Million ≈ $35.52 Million |
€-12.96 Million ≈ $-15.15 Million |
-0.426x | -121.78% |
| 2022-03-31 | €41.55 Million ≈ $48.58 Million |
€-7.99 Million ≈ $-9.34 Million |
-0.192x | -- |
About ZENTEK LTD.
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coatings under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It also… Read more